Development and Evaluation of Sample treatment platform for infectious disease immunoassays

Important results from the project

Many rapid tests lack sensitivity due to the presence of inhibitory molecules. We have developed a technology to easily get rid of the unwanted components and thereby significantly increase the sensitivity. We have proven it in a test for tuberculosis. We wanted to test the same technology for other infectious diseases such as pneumonia and legionella.

Expected long term effects

Unfortunately, it turned out that the technology could not contribute to any improvement of the two diseases named above.

Approach and implementation

Sample collected from patients at hospital and commercially available tests in the market obtained, and our technology implemented aiming to increase the test sensitivity. The results scored either by naked eyes or a reader.